 |
| |
Press Releases |
| October 15, 2009 |
|
Correlagen Announces Launch of Expanded Cardiac
Genetic Testing Services
WALTHAM, Mass., October 15, 2009 – Correlagen today announced the launch
of its CardioGeneScan test, the first comprehensive genetic test for
diagnosis of familial cardiac disease.
 Read More |
| September 28, 2009 |
|
Correlagen Announces Acquisition of System from Helicos BioSciences
WALTHAM, Mass., September 28, 2009 – Correlagen Diagnostics Inc., a
leading provider of genetic testing for disease diagnosis, today announced
the acquisition of a system from and a scientific collaboration with
Helicos BioSciences Corporation (NASDAQ: HLCS).
Read More |
| November 21, 2008 |
|
Generation Health Launches With Team of Expert Collaborators and Investors
Generation Health, Inc. , a newly formed company focused on genetic testing benefit management,
announced the completion of Series A financing from Highland Capital Partners, Correlagen
Diagnostics, D2Hawkeye, and executive management.
Read More |
| |
|
|
| July 10, 2008 |
|
Correlagen Diagnostics First Commercial Lab in New England to Offer
Inexpensive, Reliable Diagnostic Test for Marfan Syndrome
Correlagen Diagnostics, Inc., a leading provider of genetic testing services, today announced that it now offers a genetic test for Marfan Syndrome (MFS), an inherited disease that, if left untreated, typically leads to enlargement and, eventually, rupture of the body's main artery, the aorta.
Read More |
| |
|
|
| July 10, 2007 |
|
Genetic Test for a Big Heart has Big Benefits
Correlagen Diagnostics, Inc., a leading provider of genetic testing services, today announced that it is offering a genetic test for Hypertrophic Cardiomyopathy (HCM), an inherited disease that affects one out of 500 Americans.
Read More |
| |
|
|
| March 5, 2007 |
|
Correlagen Diagnostics Inc. Laboratory Receives Accreditation From College of American Pathologists
Correlagen Diagnostics, Inc. Laboratory, Worcester, Massachusetts, has been awarded an accreditation by the Commission on Laboratory Accreditation of the College of American Pathologists (CAP), based on the results of a recent on-site inspection.
Read More |
| |
|
|
| December 5, 2006 |
|
Test to Detect Risk for Early Heart Attack Offered by Correlagen Diagnostics
Correlagen Diagnostics, Inc., a leading developer of innovative molecular diagnostics, today announced the availability of a test that may help prevent death from early heart attacks.
Read More
|
| |
|
|
| August 15, 2006 |
|
Correlagen Automates Genetic Testing with New Platform; Cerner to Provide Exclusive Distribution for Hospital-Based Laboratories
Correlagen Diagnostics, Inc. today announced the availability of GeneExplorer(TM), an automated platform that enables hospital-based clinical diagnostic laboratories to perform genetic testing with limited user intervention.
Read More
|
| |
|
|
| April 7, 2006 |
|
Correlagen Diagnostics and Protedyne Corporation Partner to Form Correlagen GeneXchange™
Correlagen Diagnostics, a molecular diagnostics clinical reference laboratory, and Protedyne Corporation, an advanced industrial laboratory automation provider, today announced the creation of Correlagen GeneXchange.
Read More
|
| |
|
|
| December 20, 2005 |
|
Correlagen Diagnostics Brings Genetic Testing for Primary Immunodeficiency to Clinical Practice
Correlagen Diagnostics, Inc. announced the availability of its molecular diagnostic testing services for primary immunodeficiency, which are performed in Correlagen's CLIA certified high complexity testing laboratory.
Read More
|
| |
|
|
| November 16, 2005 |
|
Correlagen Diagnostics and Cerner Corporation Collaborate to Bring Genetic Testing to Clinical Practice
Correlagen Diagnostics, Inc. and Cerner Corporation announced today that they have signed an agreement that will enable Cerner's clients to order Correlagen's genetic tests and to receive results through Cerner Millennium® and other Cerner® solutions.
Read More
|
| |
|
|
| September 12, 2005 |
|
Correlagen Diagnostics and Children's Hospital Boston Announce Molecular Diagnostics Collaboration
Correlagen Diagnostics Inc. and Children's Hospital Boston today announce the signing of a collaboration agreement intended to accelerate the adoption of clinically useful gene testing in patient care.
Read More
|
Copyright © 2009, Correlagen Diagnostics, Inc. All rights reserved.
| |
|
|
